News
Tariffs, trade wars, lingering inflation and high interest rates - all of these drains on the economy have not been enough to plunge the U.S. into recession. How come? Simple. Most people who want a ...
Amazon.com, Inc. (NASDAQ:AMZN) is one of the Trending AI Stocks in Focus This Week. Jefferies reiterated the stock as “Buy” ...
Cayman Islands-based Bullish targets US public offering following earlier SPAC failure, operating through subsidiaries in six ...
Both Jeffries and Mamdani gave lukewarm nods about the meeting as the top House Democrat has yet to endorse a candidate for mayor.
(Reuters) -Cryptocurrency firm Bullish on Friday filed for an initial public offering in the United States. Uncertainty ...
Cryptocurrency exchange Bullish on Friday disclosed a quarterly loss compared to a year-ago profit in its paperwork for a U.S ...
(Reuters) -Exxon Mobil has lost its arbitration challenge to block Chevron's $55 billion Hess acquisition deal, but the top U ...
And he’s not alone. Sen. Chuck Schumer and Gov. Kathy Hochul have yet to weigh in on the mayoral race, even though Mamdani ...
Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on ...
Chevron prevails over Exxon in Hess megamerger, and it matters for Chevron's stock. Chevron Corp. investors breathed a little ...
Abbott Laboratories ( NYSE: ABT) was upgraded to Buy from Hold at Jefferies following its Q2 results and revised guidance, as analysts view the market reaction as “overly punitive” and see an ...
Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results